Bayesian Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-36,000	Closed	-$585K	–	643
2024 Q2	$585K	Buy	+36,000	New	+$581K	0.07%	329
2023 Q3	–	Sell	-11,837	Closed	-$283K	–	666
2023 Q2	$283K	Buy	11,837 +337	+3%	+$7.49K	0.03%	556
2023 Q1	$216K	Buy	+11,500	New	+$219K	0.03%	590
2022 Q3	–	Sell	-41,696	Closed	-$587K	–	664
2022 Q2	$587K	Buy	+41,696	New	+$778K	0.11%	285
2020 Q1	–	Sell	-5,900	Closed	-$252K	–	755
2019 Q4	$252K	Buy	+5,900	New	+$257K	0.04%	475
2017 Q4	–	Sell	-25,584	Closed	-$964K	–	528
2017 Q3	$964K	Buy	+25,584	New	+$832K	0.23%	137
2017 Q1	–	Sell	-14,800	Closed	-$427K	–	384
2016 Q4	$427K	Buy	+14,800	New	+$392K	0.11%	340